Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 13, 2024

Safety of Trastuzumab Deruxtecan With a Focus on Treatment-Related Interstitial Lung Disease and/or Pneumonitis



Additional Info

Disclosure statements are available on the authors' profiles:

The safety of trastuzumab deruxtecan (DS-8201) with a focus on interstitial lung disease and/or pneumonitis: A systematic review and single-arm meta-analysis
Cancer 2024 May 04;[EPub Ahead of Print], R Li, M Hua, J Li, W Chen, L Xu, H Meng, Z Zhang, Q Liu, Y Cui, Q Xiang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading